Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial

The Basis of Oncoimmunology

(2016) A. Karolina Palucka et al.   CELL

Neoantigen landscape dynamics during human melanoma–T cell interactions

(2016) Els M. E. Verdegaal et al.   NATURE

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

(2016) Weiping Zou et al.   Science Translational Medicine

The cancer-retina antigen recoverin as a potential biomarker for renal tumors

(2016) Marina O. Golovastova et al.   TUMOR BIOLOGY

Dimerization deficiency of enigmatic retinitis pigmentosa-linked rhodopsin mutants

(2016) Birgit Ploier et al.   Nature Communications

T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response

(2015) Christina Pfirschke et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

(2015) Dung T. Le et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

(2015) E. M. Van Allen et al.   SCIENCE

Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

(2015) N. A. Rizvi et al.   SCIENCE

Cancer and the gut microbiota: An unexpected link

(2015) Laurence Zitvogel et al.   Science Translational Medicine

Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients

(2014) Inka Zörnig et al.   INTERNATIONAL JOURNAL OF CANCER

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

(2014) Matthew M. Gubin et al.   NATURE

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

(2014) Carsten Linnemann et al.   NATURE MEDICINE

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

(2014) Alexandra Snyder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

(2014) Donald L. Morton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP

(2013) Min Lu et al.   CANCER CELL

Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination Versus Observation After Resection of Primary Tumor > 1.5 mm in Patients With Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III Trial

(2013) Alexander M.M. Eggermont et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma

(2013) Nienke van Rooij et al.   JOURNAL OF CLINICAL ONCOLOGY

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

(2013) Paul F Robbins et al.   NATURE MEDICINE

Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells

(2013) Y.-J. Liang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation

(2011) Kelly A Avery-Kiejda et al.   BMC CANCER

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Visible Light Modulates the Expression of Cancer-Retina Antigens

(2008) A. V. Bazhin et al.   MOLECULAR CANCER RESEARCH

Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway

(2008) A. R. Todeschini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA